CompletedNCT04022577
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
Official study title
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder: A Randomized Controlled Trial
Behavioural studyAges 20–64Taiwan
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 20 years to 64 years. Other eligibility criteria applied.
- Listed locations
- Taipei, TaiwanSee all locations and recruitment
- Activities
- Behavioural activities described in the protocol · Placebo comparator
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: October 1, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- National Yang Ming Chiao Tung University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Not clearly listed
- Locations
- Taiwan
- Age range
- From 20 Years to 64 Years
- Official registry ID
- NCT04022577
Recruitment & locations
CompletedTaipei
Questions about this study
Who is behind this study?
The study sponsor is National Yang Ming Chiao Tung University, a university.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 20 years to 64 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me